Galmed Pharmaceuticals Lt...
(GLMD)
undefined
undefined%
At close: undefined
3.09
2.31%
Pre-market Jan 07, 2025, 04:46 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -0.18 | -8.12 | -16.81 | -28.75 | -78.95 | -150.75 | -114.35 | -28.25 | -95.39 | -78.89 | -104.78 | -276.31 |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | 729.06 | 1.30K | 1.03K | n/a | n/a | n/a | n/a |
| PB Ratio | 0.09 | 11.23 | 17.61 | 17.98 | 20.95 | 16.90 | 89.04 | 43.24 | 47.03 | 22.87 | -939.09 | -439.66 |
| P/FCF Ratio | -0.2 | -8.15 | -16.32 | -30.15 | -97.92 | -163.04 | -116.34 | -39.43 | -117.36 | -71.74 | -722.18 | -279.68 |
| P/OCF Ratio | -0.2 | -8.15 | -16.32 | -30.2 | -98 | -164.67 | -116.55 | -39.48 | -119.56 | -77.72 | -725.9 | -282.59 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -4.43 | -11.12 | -25.97 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.93 |
| Quick Ratio | 4.81 | 4.72 | 6.29 | 6.94 | 15.05 | 33.41 | 5.00 | 3.49 | 9.31 | 34.03 | 0.09 | 1.43 |
| Current Ratio | 4.81 | 4.76 | 6.13 | 6.47 | 11.02 | 33.41 | 4.98 | 3.44 | 9.20 | 28.76 | 0.09 | 1.43 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.02 | 0.06 | 0.03 | n/a | n/a | n/a | n/a |
| Interest Coverage | 681.09 | -82.1 | -764.67 | -974.52 | -678.06 | -255.12 | -252.33 | -251.97 | n/a | n/a | -428.59 | n/a |
| Return on Equity (ROE) | -0.5 | -1.38 | -1.05 | -0.63 | -0.27 | -0.11 | -0.78 | -1.53 | -0.49 | -0.29 | 8.96 | 1.59 |
| Return on Assets (ROA) | -0.42 | -1.12 | -0.87 | -0.53 | -0.24 | -0.11 | -0.63 | -1.03 | -0.44 | -0.28 | -105.33 | -4.13 |
| Return on Capital (ROIC) | 0.54 | -1.31 | -1.07 | -0.68 | -0.32 | -0.12 | -0.78 | -1.42 | -0.5 | -0.29 | 9.57 | -12.6 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100.00% | 100.00% | 100.00% | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -483.61% | -1.13K% | -3.63K% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -479.93% | -1.13K% | -3.61K% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -525.76% | -1.14K% | -3.61K% | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | -447.15% | -1.11K% | -2.60K% | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -506.77% | -1.12K% | -3.58K% | n/a | n/a | n/a | n/a |